Get started

Healthcare

The Healthcare Sector Index $XLV - Worth Watching SPDR Select Sector Fund – Healthcare Index AMEX:XLV The chart speaks for itself, we have our breakout levels and our break down levels. We enter on a breakout and set a stop 5% under that support and we exit and or short if we fall under the two underside support levels. Below I outline some reasons why the healthcare sector is worth paying attention too. The healthcare industry is worth $808 billion in the United States as of 2021. 65% of the industry’s revenue comes from patient care. The global healthcare industry is worth $12 trillion. In the U.S National health expenditures are projected to grow 5.4 percent, on average, over the course of 2023–31 and to account for roughly 20 percent of the economy by the end of that period. The insured share of the population is anticipated to exceed 92 percent through 2023 (figures pending), in part as a result of record-high Medicaid enrolment, and then decline toward 90 percent as coverage requirements related to the COVID-19 public health emergency expire. The growth of the health-care sector is evident in employment data as well. In 1990, about 8 million Americans worked in health care; that figure has since doubled to 16 million. That’s the largest single employment segment in our economy. In addition to the above, the west in general is an aging populace that is living longer. We will need these services more than we need staples during a recession. I believe this index can help us gauge the healthcare sector and what direction it will go next. We can watch the levels outlines and make a play if we wish. We have a hard upper boundary and lower boundary on a parallel channel on the chart. You know what to do when we breach any of these levels. Outlined on the chart XLV fund provides exposure to companies in pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology industries. XLV is the oldest in the segment, as such it is used widely for strategic or tactical positions. Since XLV is both cap weighted and fishes only from the S&P 500, it tilts heavily toward mega-caps. For focused exposure to leading health care names, XLV is tough to beat. Top Five Holdings UnitedHealth Group Inc NYSE:UNH 9.63% Eli Lilly and Co NYSE:LLY 9.19% Johnson & Johnson NYSE:JNJ 7.46% Merck & Co NYSE:MRK 5.46% AbbVie Inc 5.41% Stay Healthy and Nimble Folks PUKA
AMEX:XLV
by PukaCharts
Quest Diagnostics // Buy Future Dip Notes on how I personally use my charts/NFA: Each level L1-L3 and TP1-TP3 (Or S1-S3) has a deployment percentage. The idea is to flag these levels so I can buy 11% at L1 , 28% at L2 and if L3 deploy 61% of assigned dry powder. The same in reverse goes for TP. TP1: 61%, TP2:28% and TP3:11%. If chart pivots between TP's, in-between or in Between Sell levels these percentages are still respected. I like to use the trading range to accumulate by using this tactic. Just my personal way of using this. This is not intended or made to constitute any financial advice. This is not intended or made to constitute any financial advice. FED Macro Situation Consideration: All TP's are drawn within the context of a return to FED neutral-easing policy. I do not expect these levels to be reached before tightening is over. NOT INVESTMENT ADVICE I am not a financial advisor. The Content in this TradingView Idea is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained within this idea constitutes a solicitation, recommendation, endorsement, or offer to buy or sell any securities or other financial instruments in this or in in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction. All Content on this idea post is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in the idea/post constitutes professional and/or financial advice, nor does any information on the idea/post constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. You alone assume the sole responsibility of evaluating the merits and risks associated with the use of any information or other Content on the idea/post before making any decisions based on such information.
NYSE:DGXLong
by PudgyProdigy
Netcare ready to break above the Vuvuzela?Netcare has been in its downtrend since May 2023... It shortly dropped from R16.00 down to R13.68. And then, the price has been meandering in a downtrend below the 200MA since... As long as it stays in the Vuvuzela Formation, it will continue to go down. We need a strong breakout and for the price to close above the resistance of the pattern, before we put on our horns. Once we're in, the first target will be to the top of the downtrend level at R16.19. Until then, it's a waiting game.
JSE:NTCLong
by Timonrosso
PaxMedica stock soars 110% on FDA update for lead drug PAX-101Shares of PaxMedica (NASDAQ:PXMD) shot up 110% in early trading after the biotech company said that it now expects to file its New Drug Application for PAX-101 in the second half of 2024. The biotech company said it received constructive feedback at a recent type-B meeting with the FDA that will help it complete the application. It added that most of the work required for the NDA will focus on completing the production of commercial lots of PAX-101 under CMC regulatory guidelines, which it expects to complete in the first half of 2024. PaxMedic is seeking to get the drug approved as a treatment for African Sleeping Sickness. The company is also developing it as a potential treatment for autism spectrum disorder, according to its website. The sudden surged was later on accompanied by a consolidated move. With the Trend heading towards the bears zone
PLong
by DEXWireNews
ELI LILLY Our gem on the verge of making a paradigm shift.Eli Lilly and Company (LLY) has long been one of our best investments a real gem that even withstood and was practically unaffected by the 2022 inflation crisis. For long we have been using the Fibonacci Channel to display LLY's parabolic nature having broken above the 2.0 Fibonacci extension last May. This time the price reversed much quicker than technically expected and is attempting again to break the top (Higher Lows trend-line) of the Channel Up that started in 2020. If it closes above it, then we wil target the 3.0 Fibonacci Channel extension at $700. If it gets rejected and stays within the Channel Up, we will sell and target the recent Support at $520. Note that a break above this 3-year Channel Up may constitute a paradigm shift as the stock has never hit a new upper Fibonacci level that quickly (remember it broke above the 2.0 Fib just 5 months ago). This can transcend LLY into an even more aggressive bullish nature that we can't yet quantify. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:LLY
by TradingShot
1
XLV still coiling, possible double top on the daily? On the weekly timeframe XLV continues to coil. On the daily timeframe we may have seen a double top after the rejection at the bottom of the gap (136.50 area). FWIW these options can move, but they are low volume. On high momentum days trading the same week can be effective. Personally, I prefer to bid for calls on red days and puts on green days with swing trade straddle targets in mind. I'm currently eyeing the gap above but a breakdown with a stronger market pullback is possible. I will be looking to add a long swing position after the Jackson Hole / JPow speech depending on market conditions.
AMEX:XLV
by DVM2Trader
TDOC - Teladoc bottom fishingHello. This chart is strictly a Technical Analysis of Teladoc (TDOC). I think currently we are in a point in TDOC's price action where we've reached a fundamental SUPPORT area if you look back to 2016. This could potentially be opportune BUY ZONE. TA is all about probability. The probability we go down is always there, just in this scenario i believe the probability of downside is less compared to the upside. Though i want some short term downside for TDOC, as i believe that would be the necessary catalyst to help shift trend to upside. Price will eventually rally up, especially if we are in a bull market currently. Which i believe we are in. Ill go into details on why i want it and believe this. NOTE: This is on the WEEKLY timeframe, so we are looking into a more macro scenario than if we were to look at DAILY timeframe. LAST WEEk -> We printed a candle that has a large upper wick, indicating SELLING pressure. We are also resting right on top of a major support level at around $23, indicated by green horizontal like. It wouldnt be bad for price to drop below and touch the lower 2 green lines, the sloping one and horizontal one. This would be a catalyst due to price action then, starting to confirm what is known as a BULLISH DIVERGENCE. Which is a pattern or concept where PRICE ACTION forms LOWER LOWS, as INDICATORS create HIGHER LOWERS -> Seen by the white sloping line drawn in the RSI and MACD. And the green sloping line in PRICE ACTION indicates the lower lows. *Many trades ive recently taken have followed similar patterns, ill link 1 chart to compare this to BELOW* Its for stock LMND. Heres also a SNAP SHOT. NOTICE the horizontal white line on RSI -> this is what helps me guage at when this move and UPSIDE can start or hit. If RSI breaks out above this line, we can start to see BULLISH DIVERGENCE playout. Easily i can see TDOC hitting around the $40.00 level. Going back to CURRENT price action. I believe we go down and test the lower green lines, because of all this RESISTANCE that we are facing. NOTICE: #PURPLE SLOPING RESISTANCE LINE -> This is MAJOR MAJOR resistance, created since Feb 2021. We just tested it for the 3rd time, last week. (Note: atleast 3 touches are required to weaken lines, more price touches lines -> the weaker they get.) # We also got some short term WHITE SLOPING RESISTANCE LINES. Helping to push price down # We also got the 21 EMA (YELLOW Moving average) ******Note, all these are meeting together to act as RESISTANCE. When theres so many converging, like this -> It gets a little hard or takes time to break through to upside. ***ALso i think the PURPLE line is MOST IMPORTANT. This would help reverse trend in a major macro way. SO KEEP OBSERVING. Lastly, note the ADX & DI -> This is a momentum indicator. When RED line is over Green line, it indicates BEARISH Price action, as you can see by the downtrend. Currently there is some green overlapping occuring. We have to keep observing to see how this progresses. But ideally, we'd like to see Green shoot up to above 20 level, just like the red line did in white box. CONCLUSION: I believe in the short term, we could have some downside price action coming. But sometimes, downside action could have positive ramifications. In this case, further strengthening the BULLISH DIVERGENCE forming in the charts. Indicators and current support area, indicate seller exhausting. Probabilities in my opinion point to price moving up than down. Hitting either one of the lower green support lines, could be areas where positions can be taken with stop losses set below. DISCLAIMER: This is by NO MEANS, Financial advice. I am not a financial advisor, im just a TA nerd and post these for educational purpose. Always follow your own due diligence when trading/investing. Always focus most of your energy on risk management strategies. If you like this content, please do BOOST, FOLLOW and do COMMENT, i would like others opinions on what your seeing, whether TA or FA. Thank you.
NYSE:TDOC
by SafofAllTrades
Clicks broke above the Inverse Head and Shoulders FINALLYInverse Head and Shoulders has been forming with Clicks since March 2023 as it was being formed. We've seen the price making higher lows, breakout of its year downtrend, and things are now looking better for the bulls. Other indicators confirm: 7>21>200 RSI>50 Target 1 will be quite extended and it could be a medium term hold but my first price is to R340.76 ABOUT THE COMPANY Clicks Group is a retail-led healthcare group which has been listed on the JSE Limited (Johannesburg Stock Exchange) since 1996. Clicks Group was established in 1968 in Cape Town, South Africa by entrepreneur, Jack Goldin. Clicks was originally conceived as a drugstore concept in the style of American retailers such as Walgreens and CVS, but with legislation in South Africa at the time prohibiting corporate ownership of pharmacies, the model had to be adjusted to a variety retailer. The first Clicks store was opened in St. Georges Street in Cape Town. The "Clicks" name was apparently derived from the sound that the founder, Jack Goldin, heard from a clicking stethoscope, embodying the health focus he wanted for the company. However, due to the existing legislation, the health focus was not immediately realized until later years. The Group operates through multiple retail brands like Clicks, GNC, The Body Shop, Claire's, Musica (which you can't find anymore), and more, providing a wide array of products from health and beauty to homewares. In 2003, Clicks was finally able to introduce pharmacies into their stores after South African legislation changed to allow corporate pharmacy ownership. Clicks Group has the largest retail pharmacy chain in South Africa with over 500 in-store pharmacies.
JSE:CLSLong
by Timonrosso
ACCD Going For Gap FillAccolade, Inc is seeing a move higher this week along with other healthcare stocks. Yesterday price opened and closed above diagonal resistance and is now trading in the gap price range created in late April. The lower PPO indicator shows the green PPO line above the purple signal line with both lines rising which indicates a short-term bullish trend. Both lines trending above the 0 level indicates an intermediate to long-term bullish trend. The TDI indicator shows the green RSI line above its purple signal line and above the 60 level which indicates short-term bullish momentum. The RSI line is also above its upper white Bollinger Band which indicates extreme bullish price trend; you want to stay long when the RSI is trading above this upper band, and remain cautious when it falls back below the upper band as that usually signals bullish exhaustion in the short-term. My entry price on ACCD was $13.98. My stop-loss is currently at $10.93(SL1), but SL2($13.20) can be used for more conservative trades and is where I'll likely move my stop sometime this week. I'm looking to take profit near the upper gap line around the $16 level. Should price break higher than the gap level I'll likely remain in the trade and raise my stop-loss accordingly.
NASDAQ:ACCDLong
by PrepForProfit
ALGN WCA - Cup and HandleCompany: Align Technology Inc. Ticker: ALGN Exchange: NASDAQ Sector: Healthcare Introduction: In today's analysis, we are examining Align Technology Inc. (ALGN) listed on the NASDAQ, a key player in the healthcare sector. The weekly chart shows us a potential bullish reversal in the form of a classic Cup and Handle pattern that has been taking shape over the past 448 days. Cup and Handle Pattern: The Cup and Handle pattern is a bullish continuation or reversal pattern that resembles a teacup with a handle on the right side. It is characterized by a rounded bottom, followed by a small pullback forming the handle. Analysis: Align Technology's previous trend was downward, depicted by the diagonal blue dashed resistance line. However, this downward trend appears to be interrupted by a Cup and Handle pattern, indicating a potential reversal to the upside. The horizontal neckline of the pattern is located at 367.91. The 200 EMA, currently at 348.74, is located near this horizontal neckline, underscoring the importance of this zone. The price is above the 200 EMA, signifying a bullish environment. In case of a successful breakout above the neckline, a long position may be considered. The price target in such a scenario would be 561.52, representing an estimated rise of 52.58%. Conclusion: Align Technology's weekly chart presents a promising bullish reversal setup. This setup, if confirmed by a breakout above the neckline, could offer an attractive long trading opportunity. Please remember, this analysis should form part of your overall market research and risk management strategy, and is not direct trading advice. If you found this analysis helpful, please consider liking, sharing, and following for more insights. Wishing you successful trading! Best regards, Karim Subhieh Disclaimer: This analysis is not financial advice and is intended for educational purposes only. Always conduct your own research and consult with a financial advisor before making investment decisions.
NASDAQ:ALGN
by KarimSubhieh
Life Health showing recovering finallyInv Head and Shoulders has been anticipated for months. We were just waiting for the right shoulder to form, which it has done. Next we'll need the price to close above the neckline and it should be a strong trade to buy, hold and profit. Price >200 RSI>50 Target R23.78 ABOUT THE COMPANY Life Healthcare Group is a South Africa-based healthcare provider. Origins: Life Healthcare, formerly known as Afrox Healthcare, was established in 1983. It is one of the largest private hospital operators in South Africa. Healthcare Services: Life Healthcare Group operates hospitals, provides acute care, and offers chronic disease management, among other services. It is involved in the entire healthcare spectrum, from wellness to acute interventions to rehabilitation. Global Presence: Apart from South Africa, Life Healthcare has extended its services to other countries such as Poland (through Scanmed) and India (through Max Healthcare). Large Hospital Network: Life Healthcare operates 66 healthcare facilities, including hospitals and day clinics, across South Africa. Employment: Life Healthcare Group is a significant employer, with more than 18,000 employees, contributing substantially to the local economy. Public Trading: Life Healthcare has been listed on the Johannesburg Stock Exchange since 2010.
JSE:LHCLong
by Timonrosso
Life health in good form to R23.78 Inv Head and Shoulders has formed for LHC. We just need the final right shoulder to form, break up and out of the pattern. Then we will see buying take over, driving the price up. Price >200 RSI>50 Target 1 will be R23.78 ABOUT THE COMPANY Life Healthcare is one of the largest private hospital operators in South Africa, providing acute hospital care across 64 facilities. H Establishment: Life Healthcare was established in 1983 and has grown to become a leading provider of private healthcare in South Africa. Global Presence: Apart from South Africa, it also has operations in other countries including Poland, through its subsidiary Scanmed, and in India through Max Healthcare. Service Range: The company offers a wide range of services including acute hospital care, mental health, renal dialysis, occupational health, employee wellness, and chronic disease management. Workforce: The company employs over 18,000 people and had more than 1,600 admitting doctors. Patient-Oriented Approach: Life Healthcare emphasizes a patient-centered approach and is committed to providing quality care to all patients.
JSE:LHCLong
by Timonrosso